256 related articles for article (PubMed ID: 9696366)
41. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
42. Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management.
Berg SL; Chamberlain MC
Cancer Treat Res; 2005; 125():121-46. PubMed ID: 16211887
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
44. Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies.
Jamison T; Haque E; Muhsen IN; Samarkandi H; Fakih RE; Aljurf M
Med Oncol; 2024 Jun; 41(7):177. PubMed ID: 38884819
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
Wasserstrom WR; Glass JP; Posner JB
Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
[TBL] [Abstract][Full Text] [Related]
46. Radioisotope CSF flow studies in leptomeningeal metastases.
Chamberlain MC
J Neurooncol; 1998; 38(2-3):135-40. PubMed ID: 9696363
[TBL] [Abstract][Full Text] [Related]
47. Leptomeningeal metastasis.
Taillibert S; Chamberlain MC
Handb Clin Neurol; 2018; 149():169-204. PubMed ID: 29307353
[TBL] [Abstract][Full Text] [Related]
48. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
49. Leptomeningeal metastases from a primary central nervous system melanoma: a case report and literature review.
Pan Z; Yang G; Wang Y; Yuan T; Gao Y; Dong L
World J Surg Oncol; 2014 Aug; 12():265. PubMed ID: 25142885
[TBL] [Abstract][Full Text] [Related]
50. 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
Mason WP; Yeh SD; DeAngelis LM
Neurology; 1998 Feb; 50(2):438-44. PubMed ID: 9484369
[TBL] [Abstract][Full Text] [Related]
51. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
52. Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy.
Wilson B; Sapp C; Abdeen G; Kamona A; Massarweh S
Breast Cancer Res Treat; 2012 Jan; 131(1):343-6. PubMed ID: 22037782
[TBL] [Abstract][Full Text] [Related]
53. Treatment modalities for leptomeningeal metastases.
Shapiro WR; Johanson CE; Boogerd W
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
[TBL] [Abstract][Full Text] [Related]
54. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
55. Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy.
Siegal T; Lossos A; Pfeffer MR
Neurology; 1994 Aug; 44(8):1463-9. PubMed ID: 8058150
[TBL] [Abstract][Full Text] [Related]
56. [Guideline 'Leptomeningeal metastases of solid tumours'].
Boogerd W; du Bois WF; Teepen JL; Rosenbrand CJ
Ned Tijdschr Geneeskd; 2007 Jan; 151(2):123-8. PubMed ID: 17315489
[TBL] [Abstract][Full Text] [Related]
57. Leptomeningeal metastases from solid malignancy: a review.
Taillibert S; Laigle-Donadey F; Chodkiewicz C; Sanson M; Hoang-Xuan K; Delattre JY
J Neurooncol; 2005 Oct; 75(1):85-99. PubMed ID: 16215819
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
Rudnicka H; Niwińska A; Murawska M
J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases.
Chamberlain MC; Kormanik PA
Neurology; 1996 Jun; 46(6):1674-7. PubMed ID: 8649568
[TBL] [Abstract][Full Text] [Related]
60. Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors.
Baskaran AB; Bhatia A; Kumthekar P; Boire A; Lukas RV
Future Oncol; 2023 Aug; 19(26):1801-1807. PubMed ID: 37737023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
